Temporal trends in lipid screening and therapy among youth from 2002 to 2012

Journal of Clinical Lipidology
Justin P ZachariahAndrea E Cassidy-Bushrow

Abstract

Pediatric lipid management recommendations have evolved from selective screening to universal screening to identify and target therapy for genetic dyslipidemias. Data on the success of the selective screening guidelines for lipid testing, dyslipidemia detection, and lipid management are conflicting. To determine temporal trends in lipid testing, dyslipidemia categories and pharmacotherapy in a cohort of 653,642 individual youth aged 2 to 20 years from 2002 to 2012. Summary data on lipid test results, lipid-lowering medicine (LLM) dispensings, and International Classification of Diseases, Ninth Revision diagnoses were compiled from the virtual data warehouses of 5 sites in the Cardiovascular Research Network. Temporal trends were determined using linear regression. Among the average 255,160 ± 25,506 children enrolled each year, lipid testing declined from 16% in 2002 to 11% in 2012 (P < .001 for trend). Among the entire population, the proportion newly detected each year with low-density lipoprotein cholesterol >190 mg/dL, a value commonly used to define familial hypercholesterolemia, increased over time from 0.03% to 0.06% (P = .03 for trend). There was no significant change over time in the proportion of the yearly population ...Continue Reading

References

Jun 17, 1976·The New England Journal of Medicine·M S Brown, J L Goldstein
Sep 15, 2007·BMJ : British Medical Journal·David S WaldNicholas J Wald
Jul 4, 2008·Pediatrics·Stephen R DanielsUNKNOWN Committee on Nutrition
Nov 4, 2008·Pediatrics·Emily R CoxDouglas E Mager
Nov 13, 2008·BMJ : British Medical Journal·Jorie VersmissenEric J G Sijbrands
Dec 3, 2008·Pediatrics·Tamar Lasky
Dec 25, 2009·Circulation. Cardiovascular Quality and Outcomes·Alan S GoJerry H Gurwitz
May 27, 2011·Journal of Clinical Lipidology·Stephen R DanielsUNKNOWN National Lipid Association Expert Panel on Familial Hypercholesterolemia
May 27, 2011·Journal of Clinical Lipidology·Paul N HopkinsUNKNOWN National Lipid Association Expert Panel on Familial Hypercholesterolemia
Nov 16, 2011·Pediatrics·UNKNOWN Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents, UNKNOWN National Heart, Lung, and Blood Institute
Dec 6, 2011·American Journal of Medical Genetics. Part a·Joan K MorrisNicholas J Wald
Dec 17, 2011·JAMA : the Journal of the American Medical Association·Bruce M Psaty, Frederick P Rivara
Jan 19, 2012·JAMA : the Journal of the American Medical Association·Matthew W Gillman, Stephen R Daniels
Aug 9, 2012·JAMA : the Journal of the American Medical Association·Brian K KitCyntjl Ogden
Nov 6, 2013·Circulation·Brian W McCrindleRae-Ellen W Kavey
Nov 21, 2013·The Journal of Pediatrics·Damon B DixonJulia Steinberger
May 6, 2014·JAMA : the Journal of the American Medical Association·Samuel R VinciSarah D de Ferranti
Aug 28, 2014·Circulation. Cardiovascular Quality and Outcomes·Karen L MargolisPatrick J O'Connor
Sep 10, 2014·JAMA : the Journal of the American Medical Association·D Meeike KustersBarbara A Hutten
Oct 1, 2014·JAMA : the Journal of the American Medical Association·Sean T GregoryLaurel A Copeland
May 27, 2015·European Heart Journal·Albert WiegmanUNKNOWN European Atherosclerosis Society Consensus Panel

❮ Previous
Next ❯

Citations

Feb 23, 2019·Clinical Pediatrics·Lisa HerringtonElizabeth Hisle-Gorman
Jul 18, 2020·Circulation. Cardiovascular Quality and Outcomes·Emily F GregoryAlexander G Fiks
Nov 25, 2020·American Heart Journal·Justin H BergerJulie A Brothers
Jan 19, 2021·Current Treatment Options in Pediatrics·Scott Leopold, Justin P Zachariah
Feb 4, 2021·Current Opinion in Endocrinology, Diabetes, and Obesity·Don P WilsonPatrick M Moriarty
Jul 13, 2021·HGG Advances·Jennifer K Wagner, Michelle N Meyer
Jul 31, 2021·American Journal of Preventive Cardiology·Sophia Figueroa KatzJoshua W Knowles
Aug 29, 2021·Current Atherosclerosis Reports·Amy L PetersonDon P Wilson

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Related Papers

Clinical Cardiology
Peter O Kwiterovich, Samuel S Gidding
Atherosclerosis. Supplements
Herbert Schuster, National Cholesterol Education Program (NCEP) Adult Treatment Panel III (ATP III)
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne
J G FodorP R McPherson
© 2021 Meta ULC. All rights reserved